Researcher pleads guilty to taking fees

Dec 09, 2006

A U.S. scientist working on Alzheimer's has pleaded guilty to accepting consulting fees and travel expenses from a drug manufacturer without proper approval.

As part the agreement reached Friday, Pearson Sunderland III, chief of geriatric psychiatry of the National Institute of Mental Health, will be sentenced to two years of supervised probation and must forfeit $300,000, the Baltimore Sun said. Charged with conflict of interest, Sunderland admitted to accepting about $285,000 from Pfizer Inc. without authorization.

The institute is a part of the National Institutes of Health, which has said the arrangements between private companies and agency scientists was the worst scandal in the agency's history.

NIH officials said more than 40 scientists were thought to have engaged in outside, fee-based relationships with private companies. Most were disciplined internally or retired, agency officials said.

Rep. John D. Dingell, D-Mich., expected to lead the House Energy and Commerce Committee in January, said the case raises questions about NIH management.

"Sunderland remained on the payroll for years after NIH was given information from this committee about this conflict," Dingell said in a statement. "Will a criminal conviction for conflict of interest be enough to get someone fired from NIH?"

Copyright 2006 by United Press International

Explore further: Radiologist recommendations for chest CT have high clinical yield

add to favorites email to friend print save as pdf

Related Stories

French watchdog urges no 3D for under sixes

Nov 05, 2014

A French health watchdog recommended Thursday that children under six be denied access to 3D films, computers and video games, and that those up to 13 have "moderate" access.

Kim Dotcom blasts New Zealand police 'cover-up'

Aug 30, 2013

Megaupload founder Kim Dotcom accused New Zealand police of selectively applying the law Friday after they opted not to prosecute intelligence officials who illegally spied on him.

Recommended for you

New approach to particle therapy dosimetry

Dec 19, 2014

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.